RT Book, Section
A1 Blumen, Ira J.
A1 Ahn, James
A2 Schafermeyer, Robert
A2 Tenenbein, Milton
A2 Macias, Charles G.
A2 Sharieff, Ghazala Q.
A2 Yamamoto, Loren G.
SR Print(0)
ID 1105687864
T1 High-Altitude Illness
T2 Strange and Schafermeyer's Pediatric Emergency Medicine, 4e
YR 2014
FD 2014
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-182926-7
LK accessemergencymedicine.mhmedical.com/content.aspx?aid=1105687864
RD 2024/04/19
AB High-altitude  illness  (HAI)  often  affects  young  and  otherwise  healthy  individuals.  It  progresses  from  acute  mountain  sickness  (AMS)  to  potentially  life-threatening  high-altitude  pulmonary  edema  (HAPE)  and  high-altitude  cerebral  edema  (HACE).Acetazolamide  (Diamox)  has  been  shown  to  be  very  effective  for  acclimatization  when  staging  is  not  possible  or  with  individuals  who  are  at  an  increased  risk  of  HAI.Definitive  treatment  of  HACE  is  descent.  High-flow  oxygen  is  indicated  as  soon  as  symptoms  are  recognized  and  dexamethasone,  at  an  initial  dose  of  1  to  2  mg/kg  orally  or  intramuscularly,  can  produce  dramatic  improvement.HAPE  is  the  leading  cause  of  high-altitude  death  other  than  trauma.